LobbyingDR. Stephen Soloway lobbying by quarter
DR. Stephen Soloway's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues.
DR. Stephen Soloway
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $50K | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$50K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES3 reports
- SENATE3 reports
- Health & Human Services, Dept of (HHS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Merkava Strategies | $50K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/03for Q2 | Merkava Strategies | Under $5,000 |
| 05/22for Q1 | Merkava Strategies | Under $5,000 |
| 01/23for Q4 2025 | Merkava Strategies | Under $5,000 |
| 25/11/06for Q3 2025 | Merkava Strategies | Under $5,000 |
| 25/08/05for Q2 2025 | Merkava Strategies | Under $5,000 |
| 25/05/06for Q1 2025 | Merkava Strategies | Under $5,000 |
| 25/02/05for Q4 2024 | Merkava Strategies | Under $5,000 |
| 24/11/08for Q3 2024 | Merkava Strategies | Under $5,000 |
| 24/08/06for Q2 2024 | Merkava Strategies | Under $5,000 |
| 24/05/05for Q1 2024 | Merkava Strategies | Under $5,000 |
| 24/02/05for Q4 2023 | Merkava Strategies | Under $5,000 |
| 23/11/14for Q3 2023 | Merkava Strategies | Under $5,000 |
| 23/08/20for Q2 2023 | Merkava Strategies | Under $5,000 |
| 23/05/27for Q1 2023 | Merkava Strategies | Under $5,000 |
| 23/02/25for Q4 2022 | Merkava Strategies | $50K |